Astrogliosis
1 paper
- Animals1
Funding
3 grants since 2023National Institute on AgingUS$15.8m
Metabolic determinants of reactive astrogliosis and cognitive heterogeneity in aging
National Institute on AgingUniversity of Oklahoma Hlth Sciences CtrUS$434.2k2024–2029
National Institute on AgingUniversity of Texas Hlth Science CenterUS$622.8k2021–2026
National Institute on AgingUniversity of Pittsburgh at PittsburghUS$6.7m2004–2028
Latest
18 in 12 monthsFrontiers in Neuroscience
Raloxifene and progesterone neuroprotection in a female mouse model of Parkinson's disease
Experiments in miceProgesterone
Alzheimer's & Dementia
Synergistic association of insomnia and anxiety with cognitive impairment and dementia in older adults
Cohort study in peopleCognitive impairment
Research Square
Effects on cognition of regional astrogliosis assessed by ¹⁸F-SMBT-1 PET in non- demented individuals
Preprint: cohort study of 94 peopleMechanisms
bioRxiv
Cytoplasmic DNA Sensing Links LINE-1 Expression to Neuronal Senescence in Alzheimer's Disease
Preprint: experiments in human cellsCellular senescence
AAIC 2025 Abstract
Synergistic effects of GFAP with TNFR1 and TNFR2 on conversion to AD dementia and overall survival across the Alzheimer's disease spectrum
Cohort study of 190 peopleDementia
AAIC 2025 Abstract
Modulatory effect of glial fibrillary acidic protein (GFAP) levels on the association between plasma p ‐tau217 levels and cognitive decline in older adults
Cohort study of 354 peopleGFAP
AAIC 2025 Abstract
Reactive Astrogliosis predicts Amyloid Accumulation before the Preclinical Stage of Alzheimer's Disease
Cohort study in peopleAlzheimer's disease
AAIC 2025 Abstract
Vascular pathology drives the association of plasma GFAP with gray matter atrophy and cognitive decline in amyloid‐negative individuals
Cohort study of 324 peopleGFAP